Predictive Oncology Inc. — Director's Dealing 2021

Jan 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Predictive Oncology Inc. (POAI)
CIK: 0001446159
Period of Report: 2020-12-31

Reporting Person: CHUNG-WELCH NANCY (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-31	Stock Options (right to buy)	$0.7324	A	34135	Acquired	2030-12-31	Common Stock (34135)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	4698	Direct